 | Up a level |
Lovly, Christine M., McDonald, Nerina T., Chen, Heidi, Ortiz-Cuaran, Sandra, Heukamp, Lukas C., Yan, Yingjun 
ORCID: 0000-0001-6963-7112, Florin, Alexandra, Ozretic, Luka, Lim, Diana, Wang, Lu ORCID: 0000-0002-0073-0666, Chen, Zhao, Chen, Xi, Lu, Pengcheng, Paik, Paul K., Shen, Ronglai, Jin, Hailing, Buettner, Reinhard, Ansen, Sascha, Perner, Sven, Brockmann, Michael, Bos, Marc, Wolf, Juergen, Gardizi, Masyar, Wright, Gavin M., Solomon, Benjamin, Russell, Prudence A., Rogers, Toni-Maree, Suehara, Yoshiyuki, Red-Brewer, Monica, Tieu, Rudy, de Stanchina, Elisa, Wang, Qingguo ORCID: 0000-0002-5125-3724, Zhao, Zhongming, Johnson, David H., Horn, Leora, Wong, Kwok-Kin, Thomas, Roman K., Ladanyi, Marc and Pao, William
(2014).
Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer.
Nat. Med., 20 (9).
S. 1027 - 1035.
NEW YORK:
NATURE PUBLISHING GROUP.
ISSN 1546-170X